1. From the Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring (T.M.P., M.R.T., R.P.), and the Breast Cancer Program, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (T.M.P.) — both in Maryland.